246 related articles for article (PubMed ID: 9774441)
21. Chemical dissection of the effects of tyrosine phosphorylation of SHP-2.
Lu W; Shen K; Cole PA
Biochemistry; 2003 May; 42(18):5461-8. PubMed ID: 12731888
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2.
Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A
Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198
[TBL] [Abstract][Full Text] [Related]
23. Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation.
Frank C; Keilhack H; Opitz F; Zschörnig O; Böhmer FD
Biochemistry; 1999 Sep; 38(37):11993-2002. PubMed ID: 10508402
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate.
Stuckey JA; Schubert HL; Fauman EB; Zhang ZY; Dixon JE; Saper MA
Nature; 1994 Aug; 370(6490):571-5. PubMed ID: 8052312
[TBL] [Abstract][Full Text] [Related]
25. The molecular details of WPD-loop movement differ in the protein-tyrosine phosphatases YopH and PTP1B.
Brandão TA; Johnson SJ; Hengge AC
Arch Biochem Biophys; 2012 Sep; 525(1):53-9. PubMed ID: 22698963
[TBL] [Abstract][Full Text] [Related]
26. Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases.
Selner NG; Luechapanichkul R; Chen X; Neel BG; Zhang ZY; Knapp S; Bell CE; Pei D
Biochemistry; 2014 Jan; 53(2):397-412. PubMed ID: 24359314
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of human protein tyrosine phosphatase 1B.
Barford D; Flint AJ; Tonks NK
Science; 1994 Mar; 263(5152):1397-404. PubMed ID: 8128219
[TBL] [Abstract][Full Text] [Related]
28. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.
Salmeen A; Andersen JN; Myers MP; Tonks NK; Barford D
Mol Cell; 2000 Dec; 6(6):1401-12. PubMed ID: 11163213
[TBL] [Abstract][Full Text] [Related]
30. Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures.
Brandão TA; Robinson H; Johnson SJ; Hengge AC
J Am Chem Soc; 2009 Jan; 131(2):778-86. PubMed ID: 19140798
[TBL] [Abstract][Full Text] [Related]
31. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
32. Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.
Martin A; Tsui HW; Shulman MJ; Isenman D; Tsui FW
J Biol Chem; 1999 Jul; 274(31):21725-34. PubMed ID: 10419485
[TBL] [Abstract][Full Text] [Related]
33. The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.
Scapin G; Patel S; Patel V; Kennedy B; Asante-Appiah E
Protein Sci; 2001 Aug; 10(8):1596-605. PubMed ID: 11468356
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
Villa F; Deak M; Bloomberg GB; Alessi DR; van Aalten DM
J Biol Chem; 2005 Mar; 280(9):8180-7. PubMed ID: 15611135
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of human dual specificity phosphatase, JNK stimulatory phosphatase-1, at 1.5 A resolution.
Yokota T; Nara Y; Kashima A; Matsubara K; Misawa S; Kato R; Sugio S
Proteins; 2007 Feb; 66(2):272-8. PubMed ID: 17068812
[TBL] [Abstract][Full Text] [Related]
36. Conformational and dynamic changes of Yersinia protein tyrosine phosphatase induced by ligand binding and active site mutation and revealed by H/D exchange and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Wang F; Li W; Emmett MR; Hendrickson CL; Marshall AG; Zhang YL; Wu L; Zhang ZY
Biochemistry; 1998 Nov; 37(44):15289-99. PubMed ID: 9799489
[TBL] [Abstract][Full Text] [Related]
37. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
38. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
[TBL] [Abstract][Full Text] [Related]
39. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.
Eck MJ; Pluskey S; Trüb T; Harrison SC; Shoelson SE
Nature; 1996 Jan; 379(6562):277-80. PubMed ID: 8538796
[TBL] [Abstract][Full Text] [Related]
40. Large-scale structural analysis of the classical human protein tyrosine phosphatome.
Barr AJ; Ugochukwu E; Lee WH; King ON; Filippakopoulos P; Alfano I; Savitsky P; Burgess-Brown NA; Müller S; Knapp S
Cell; 2009 Jan; 136(2):352-63. PubMed ID: 19167335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
